← FDA ENFORCEMENT
D-0203-2024Class II

AnazaoHealth Corporation

Recalling firm
AnazaoHealth Corporation
Product type
Drug
Status
Terminated
Report date
2024-01-03
Distribution
Nationwide in the USA.
Firm state
NV
Product quantity
5,707 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Presence of Particulate Matter.

Product description

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Code / lot info

Lots: 505075, Exp: 02/05/24; 505596, Exp: 02/06/24; 506155, Exp: 02/07/24; 508103, Exp: 02/13/24; 510837, Exp: 02/19/24; 512411, Exp: 02/20/24; 514856, Exp: 02/25/24; 515642, Exp: 02/28/24; 518309, Exp: 03/05/24; 524262, 524266, Exp: 03/12/24; 524909, Exp: 03/13/24; 526526, Exp: 03/16/24; 529204, Exp: 03/18/24; 530858, Exp: 03/20/24; 535766, Exp: 03/30/24

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.